Genetically modified worms can now produce and deliver drugs inside a living body, scientists say
Researchers are developing genetically modified hookworms capable of producing and delivering therapeutic agents directly within a living host.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Early reports highlighted potential applications for treating conditions like IBS and neutralizing toxins, though no further updates on human trials or broader developments followed. Coverage of the breakthrough quieted without a definitive conclusion in subsequent reporting.
Epilogue added 156d ago, after coverage quieted.
The brief
Scientists have successfully engineered hookworms to secrete specific antibodies, including anti-tetrodotoxin human single-chain antibodies, within an internal environment. Testing involving hamsters has demonstrated the capability of these organisms to deliver detoxifying agents.
Coverage from outlets including R&D World, WashU Medicine, and Nature highlights the technical development of these transgenic worms. Reports from Science News, Live Science, and The Sun emphasize potential applications for treating conditions like IBS and providing internal drug delivery systems.
Future developments remain dependent on further research into the safety and efficacy of using these organisms in a biological setting. Coverage does not yet specify a timeline for human clinical trials or regulatory approval processes.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 157d ago.
Quick answers
What have the engineered hookworms successfully produced?
They have been engineered to secrete therapeutics, specifically anti-tetrodotoxin human single-chain antibodies.
Have these worms been tested on living subjects?
Yes, Washington University engineers have utilized the worms to deliver detox antibodies in hamsters.
What potential medical uses are being explored?
Potential applications include internal drug delivery and the treatment of conditions such as irritable bowel syndrome (IBS).
Coverage (7)
- Genetically modified hookworms could make therapeutics in a host R&D World · 160d ago
- Special WORMS could wriggle life-saving drugs inside humans and treat IBS The Sun · 160d ago
- Washington University engineers hookworms to deliver detox antibodies in hamsters 동아사이언스 · 160d ago
- Genetically modified hookworms produce and deliver therapeutics WashU Medicine · 160d ago
- Transgenic hookworm secretes anti-tetrodotoxin human single chain antibody Nature · 160d ago
- Engineered hookworms could one day dispense drugs from inside your gut Science News · 160d ago
- Genetically modified worms can now produce and deliver drugs inside a living body, scientists say Live Science · 160d ago
Topics
Related trends
The Largest Alzheimer's Genetics Study Yet Found 48 New Links. The Most Promising Clue Isn't About Memory
The largest Alzheimer's genetics study yet has uncovered 48 new links, highlighting how genetics and sleep interact.
Cellectis will shed 70% of workforce as part of in vivo pivot
Cellectis announces 70% workforce reduction and strategic pivot to in vivo gene editing as Q3 revenue drops to $14.8M.
Not afraid of ghosts: Curiosity and fearlessness apparent in German shepherd genes
A study from Uppsala University and the Swedish University of Agricultural Sciences finds that German shepherds bred for working roles are genetically distinct from show-line dogs, showing more curiosity and less fear.
Decoding the regulatory programs governing glioblastoma plasticity
Recent scientific studies examine how glioblastoma cancer cells switch identities and navigate complex spatial architectures.
Scientists Recovered 22,000-Year-Old Human DNA From Cave Dirt
Researchers have successfully recovered 22,000-year-old human DNA directly from cave soil, revealing unexpected prehistoric connections across Europe.
B-Vitamin Supplement Can Treat Psoriasis, a Skin Condition with No Cure
A cheap B‑vitamin pill shows promise in easing psoriasis symptoms, sparking hope for millions with the incurable skin disease